Extension of tax deduction for BioNexus status companies

PrintMailRate-it
The tax incentives for investors who invest in BioNexus status companies will be extended to 31 December 2022.  
  
BioNexus companies are companies which are engaged in the following businesses:
  • Biology
  • Medicine
  • Anthropology
  • Ecology; and
  • Any other branches of science.
  
This means that qualifying investments made between 1 January 2021 to 31 December 2022 will be allowed for the above mentioned tax deduction.
 
Taxpayer investors are eligible to claim a tax deduction of the actual investments made in BioNexus status companies against their business income in the year of assessment where the investments is made.

From The Newsletter

Contact

Contact Person Picture

Priya Selvanathan

Associate Partner

+65 6238 6770

Send inquiry

Skip Ribbon Commands
Skip to main content
Deutschland Weltweit Search Menu